This statistic depicts the share of clinical trials funded by Novartis approved by AIFA (Italian Pharmaceutical Agency) in Italy in 2017, by stage. According to data, the largest percentage of clinical studies approved by AIFA were in the second stage (37.3 percent), whereas only 2.3 percent of trials were conducted in the fourth stage.
Share of clinical trials funded by Novartis approved by AIFA (Italian Pharmaceutical Agency) in Italy in 2017, by stage
Loading statistic...
Basic Account
Get to know the platform
You only have access to basic statistics.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$59 USD $39 USD / Month *
in the first 12 months
Professional Account
Full access
Corporate solution including all features.
* Prices do not include sales tax.
Statistics on Pharmaceutical industry in Spain
Main figures
6
- Basic Statistic Production value of pharmaceutical products & preparations in Spain 2009-2020
- Basic Statistic Turnover of the manufacture of pharmaceutical products in Spain 2009-2020
- Basic Statistic Workers in the Spanish pharmaceutical industry 2008-2020
- Premium Statistic Wages earned in the pharmaceutical industry sector in Spain 2008-2020
- Basic Statistic Spain: number of manufacturers of basic pharmaceutical products 2009-2020
- Basic Statistic Spain: number of pharmaceutical preparations manufacturers 2009-2020
International trade
6
- Premium Statistic Value of pharmaceutical products exported from Spain 2002-2021
- Premium Statistic Value of pharmaceutical products imported by Spain 2002-2021
- Premium Statistic Export value of pharmaceutical products in Spain 2021, by type
- Premium Statistic Import value of pharmaceutical products in Spain 2021, by type
- Premium Statistic Pharmaceutical products export value in Spain 2021, by country of destination
- Premium Statistic Import value of pharmaceutical products in Spain 2021, by country
Pharmaceutical sales
6
- Premium Statistic Net sales of drugs in pharmacies in Spain 2012-2021
- Premium Statistic Net value of drugs sold in pharmacies by therapeutic group in Spain 2021
- Premium Statistic Value share of drugs sold in pharmacies by therapeutic group in Spain 2021
- Premium Statistic Volume of drugs sold in pharmacies by therapeutic group in Spain 2021
- Premium Statistic Volume share of drugs sold in pharmacies by therapeutic group in Spain 2021
- Premium Statistic Average price of drugs sold in pharmacies by therapeutic group in Spain 2021
Pharmaceutical expenditure of the National Health System
6
- Premium Statistic Budget expenditure on health benefits & pharmacy in Spain 2003-2022
- Premium Statistic NHS expenditure on prescribed medicines in pharmacies in Spain 2010-2021
- Premium Statistic Average cost of medical prescriptions in pharmacies in Spain 2010-2021
- Premium Statistic State-funded drug prescriptions dispensed in pharmacies in Spain 2010-2021
- Premium Statistic NHS expenditure per prescription dispensed in pharmacies in Spain 2021, by region
- Premium Statistic Share of per capita pharmaceutical expenditure in Spain 2021, by region
Research and development
6
- Premium Statistic Share of total R&D spending in Spain in 2020, by industrial sector
- Premium Statistic R&D expenditure in the pharmaceutical industry in Spain 2008-2021
- Premium Statistic R&D employment within the pharmaceutical industry in Spain 2008-2021
- Premium Statistic Pharmaceutical R&D spending by type Spain 2021
- Premium Statistic Internal and external R&D expenditure in the pharmaceutical industry Spain 2013-2021
- Premium Statistic External R&D expenditure in the pharmaceutical industry by region Spain 2021
Company rankings
6
- Premium Statistic Leading basic pharmaceutical products manufacturers in Spain in 2020
- Premium Statistic Leading pharmaceutical preparations manufacturers in Spain in 2020
- Premium Statistic Leading pharmaceutical goods wholesalers in Spain in 2020
- Premium Statistic Corporate reputation of leading pharmaceutical companies in Spain in 2022
- Premium Statistic Sales value of the largest-selling prescription drugs in Spain 2020
- Premium Statistic Sales volume of the largest-selling prescription drugs in Spain 2019-2020
Further related statistics
19
- Italy: clinical trials of Novartis 2017, by therapeutic area
- Italy: patients involved in clinical trials of Novartis 2017, by therapeutic area
- Italy: patients involved in clinical trials of Novartis 2017, by region
- Italy: value of purchased goods and services of Novartis 2017, by region
- Italy: value of taxes paid by Novartis 2013-2017
- Number of employees of Novartis in Italy 2017, by region
- Distribution of employees of Novartis in Italy 2017, by age group
- Distribution of employees of Novartis in Italy 2015-2017, by gender
- Italy: investments of Novartis 2013-2017
- Italy: investments of Novartis in research and development 2013-2017
- Novartis AG's growth products as percent of pharma revenue 2009-2016
- M&A capacities - changes for the global pharma industry 2008-2015
- Novartis AG - doses sold for prevention of major diseases 2013
- Business risks at selected pharmaceutical companies 2011
- Domestic partnership deals in China's pharma industry 2013-2021
- Projected 2019 revenue for top drugs approved U.S. 2014
- Foreign partnership in China's pharma industry 2013-2021
- World pharmaceutical select subsector value share 2017
- GAAP earnings - adjustments of selected U.S. pharmaceutical companies 2011
Further Content: You might find this interesting as well
Statistics
- Italy: clinical trials of Novartis 2017, by therapeutic area
- Italy: patients involved in clinical trials of Novartis 2017, by therapeutic area
- Italy: patients involved in clinical trials of Novartis 2017, by region
- Italy: value of purchased goods and services of Novartis 2017, by region
- Italy: value of taxes paid by Novartis 2013-2017
- Number of employees of Novartis in Italy 2017, by region
- Distribution of employees of Novartis in Italy 2017, by age group
- Distribution of employees of Novartis in Italy 2015-2017, by gender
- Italy: investments of Novartis 2013-2017
- Italy: investments of Novartis in research and development 2013-2017
- Novartis AG's growth products as percent of pharma revenue 2009-2016
- M&A capacities - changes for the global pharma industry 2008-2015
- Novartis AG - doses sold for prevention of major diseases 2013
- Business risks at selected pharmaceutical companies 2011
- Domestic partnership deals in China's pharma industry 2013-2021
- Projected 2019 revenue for top drugs approved U.S. 2014
- Foreign partnership in China's pharma industry 2013-2021
- World pharmaceutical select subsector value share 2017
- GAAP earnings - adjustments of selected U.S. pharmaceutical companies 2011
The European House – Ambrosetti . (November 1, 2018). Share of clinical trials funded by Novartis approved by AIFA (Italian Pharmaceutical Agency) in Italy in 2017, by stage [Graph]. In Statista. Retrieved January 28, 2023, from https://www.statista.com/statistics/1015074/clinical-trials-of-novartis-approved-by-aifa-by-stage-in-italy/
The European House – Ambrosetti . "Share of clinical trials funded by Novartis approved by AIFA (Italian Pharmaceutical Agency) in Italy in 2017, by stage." Chart. November 1, 2018. Statista. Accessed January 28, 2023. https://www.statista.com/statistics/1015074/clinical-trials-of-novartis-approved-by-aifa-by-stage-in-italy/
The European House – Ambrosetti . (2018). Share of clinical trials funded by Novartis approved by AIFA (Italian Pharmaceutical Agency) in Italy in 2017, by stage. Statista. Statista Inc.. Accessed: January 28, 2023. https://www.statista.com/statistics/1015074/clinical-trials-of-novartis-approved-by-aifa-by-stage-in-italy/
The European House – Ambrosetti . "Share of Clinical Trials Funded by Novartis Approved by Aifa (Italian Pharmaceutical Agency) in Italy in 2017, by Stage." Statista, Statista Inc., 1 Nov 2018, https://www.statista.com/statistics/1015074/clinical-trials-of-novartis-approved-by-aifa-by-stage-in-italy/
The European House – Ambrosetti , Share of clinical trials funded by Novartis approved by AIFA (Italian Pharmaceutical Agency) in Italy in 2017, by stage Statista, https://www.statista.com/statistics/1015074/clinical-trials-of-novartis-approved-by-aifa-by-stage-in-italy/ (last visited January 28, 2023)
Share of clinical trials funded by Novartis approved by AIFA (Italian Pharmaceutical Agency) in Italy in 2017, by stage [Graph], The European House – Ambrosetti , November 1, 2018. [Online]. Available: https://www.statista.com/statistics/1015074/clinical-trials-of-novartis-approved-by-aifa-by-stage-in-italy/